TURANDOT 1: A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, Parallel, Dose-Ranging Study to Evaluate the Efficacy and Safety of PF-00547659 in Subjects with Moderate to Severe Ulcerative Colitis

Grants and Contracts Details

StatusFinished
Effective start/end date7/11/13 → 6/30/16

Funding

  • ICON Clinical Research: $43,313.00